UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.193

Sortiert nach

Granulocyte-macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non-small-cell lung cancer

JNCI : Journal of the National Cancer Institute, 2004-02, Vol.96 (4), p.326-331

2004

Volltextzugriff (PDF)

Sunitinib Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel for First-Line Treatment of Patients With Advanced Breast Cancer: A Phase III, Randomized, Open-Label Trial

Clinical breast cancer, 2011-04, Vol.11 (2), p.82-92

2011

Volltextzugriff (PDF)

Phase II randomized trial of weekly and every-3-week ixabepilone in metastatic breast cancer patients

Breast cancer research and treatment, 2013-11, Vol.142 (2), p.381-388

2013

Volltextzugriff (PDF)

Targeting FGFR with Dovitinib (TKI258): Preclinical and Clinical Data in Breast Cancer

Clinical cancer research, 2013-07, Vol.19 (13), p.3693-3702

2013

Volltextzugriff (PDF)

Adjuvant Immunization of HLA-A2–Positive Melanoma Patients With a Modified gp100 Peptide Induces Peptide-Specific CD8+ T-Cell Responses

Journal of clinical oncology, 2003-04, Vol.21 (8), p.1562-1573

2003

Volltextzugriff (PDF)

Phase I Trial of BAY 50-4798, an Interleukin-2–Specific Agonist in Advanced Melanoma and Renal Cancer

Clinical cancer research, 2007-06, Vol.13 (11), p.3312-3319

2007

Volltextzugriff (PDF)

Phase II, Multicenter, Single-Arm, Feasibility Study of Eribulin Combined With Capecitabine for Adjuvant Treatment in Estrogen Receptor-Positive, Early-Stage Breast Cancer

Clinical breast cancer, 2016-02, Vol.16 (1), p.31-37

2016

Volltextzugriff (PDF)

Results of a phase II open-label, nonrandomized trial of oral satraplatin in patients with metastatic breast cancer

Breast cancer research and treatment, 2009-11, Vol.118 (2), p.361-367, Article 361

2009

Volltextzugriff (PDF)

Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2 and Interferon in Patients With Metastatic Renal Cell Carcinoma

Journal of clinical oncology, 2005-01, Vol.23 (1), p.133-141

2005

Volltextzugriff (PDF)

Vaccination of women with metastatic breast cancer, using a costimulatory gene (CD80)-modified, HLA-A2-matched, allogeneic, breast cancer cell line: Clinical and immunological results

Human gene therapy, 2003-07, Vol.14 (11), p.1117-1123

2003

Volltextzugriff (PDF)

Identification of tumor-specific antibodies in patients with breast cancer vaccinated with gene-modified allogeneic tumor cells

Journal of immunotherapy (1997), 2003-03, Vol.26 (2), p.163

2003

Volltextzugriff (PDF)

Immune effects of escalating doses of granulocyte-macrophage colony-stimulating factor added to a fixed, low-dose, inpatient interleukin-2 regimen: a randomized phase I trial in patients with metastatic melanoma and renal cell carcinoma

Journal of immunotherapy (1997), 2003-03, Vol.26 (2), p.130

2003

Volltextzugriff (PDF)

The Effects of Treatment with Interleukin-1α on Platelet Recovery after High-Dose Carboplatin

The New England journal of medicine, 1993-03, Vol.328 (11), p.756-761

1993

Volltextzugriff (PDF)

Computed tomography in staging of patients with melanoma metastatic to the regional nodes

Annals of surgical oncology, 1997-07, Vol.4 (5), p.396-402

1997

Volltextzugriff (PDF)

Chronic Expanding Hematoma within a Periprosthetic Breast Capsule

Plastic and reconstructive surgery (1963), 1996-06, Vol.97 (7), p.1469-1472

1996

Volltextzugriff (PDF)

A Randomized Placebo-Controlled Trial of Recombinant Human Interleukin-11 in Cancer Patients With Severe Thrombocytopenia Due To Chemotherapy

Blood, 1996-05, Vol.87 (9), p.3607-3614

1996

Volltextzugriff (PDF)

Interleukin 2 and lymphokine-activated killer cell therapy : analysis of a bolus interleukin 2 and a continuous infusion interleukin 2 regimen

Cancer research (Chicago, Ill.), 1990-11, Vol.50 (22), p.7343-7350

1990

Volltextzugriff (PDF)

Management of Parotid Leakage Following Rhytidectomy

Plastic and reconstructive surgery (1963), 1996-10, Vol.98 (5), p.795-797

1996

Volltextzugriff (PDF)

Interleukin 1α Increases Serum Leptin Concentrations in Humans

The journal of clinical endocrinology and metabolism, 1997-09, Vol.82 (9), p.3084-3086

1997

Volltextzugriff (PDF)

The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies

Journal of clinical oncology, 1992-07, Vol.10 (7), p.1141-1152

1992

Volltextzugriff (PDF)

Peripheral T lymphocytes from women with breast cancer exhibit abnormal protein expression of several signaling molecules

International journal of cancer, 1998-09, Vol.78 (1), p.16-20

1998

Volltextzugriff (PDF)

Phase II study of carmustine, dacarbazine, cisplatin, and tamoxifen in advanced melanoma: a Southwest Oncology Group study

Journal of clinical oncology, 1998-02, Vol.16 (2), p.664-669

1998

Volltextzugriff (PDF)

Evaluation of a combined calcium sodium alginate and bio-occlusive membrane dressing in the management of split-thickness skin graft donor sites

Annals of plastic surgery, 2001-04, Vol.46 (4), p.405-408

2001

Volltextzugriff (PDF)

Intraperitoneal lymphokine-activated killer-cell and interleukin-2 therapy for malignancies limited to the peritoneal cavity

Journal of clinical oncology, 1990-10, Vol.8 (10), p.1618-1629

1990

Volltextzugriff (PDF)

Clinical evaluation of intraperitoneal Pseudomonas exotoxin immunoconjugate OVB3-PE in patients with ovarian cancer

Journal of clinical oncology, 1991-12, Vol.9 (12), p.2095-2103

1991

Volltextzugriff (PDF)

1 – 25 von 1.193

Suche als RSS-Feed

Aktive Filter

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.132)
Mit Volltextzugriff
(961)

Publikationsform

Artikel
(1.191)
Bücher
(1)
Webseiten
(1)

Sprache

Englisch
(1.193)
Japanisch
(241)
Norwegisch
(2)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Granulocyte-macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non-small-cell lung cancer

Sunitinib Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel for First-Line Treatment of Patients With Advanced Breast Cancer: A Phase III, Randomized, Open-Label Trial

Phase II randomized trial of weekly and every-3-week ixabepilone in metastatic breast cancer patients

Targeting FGFR with Dovitinib (TKI258): Preclinical and Clinical Data in Breast Cancer

Adjuvant Immunization of HLA-A2–Positive Melanoma Patients With a Modified gp100 Peptide Induces Peptide-Specific CD8+ T-Cell Responses

Phase I Trial of BAY 50-4798, an Interleukin-2–Specific Agonist in Advanced Melanoma and Renal Cancer

Phase II, Multicenter, Single-Arm, Feasibility Study of Eribulin Combined With Capecitabine for Adjuvant Treatment in Estrogen Receptor-Positive, Early-Stage Breast Cancer

Results of a phase II open-label, nonrandomized trial of oral satraplatin in patients with metastatic breast cancer

Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2 and Interferon in Patients With Metastatic Renal Cell Carcinoma

Vaccination of women with metastatic breast cancer, using a costimulatory gene (CD80)-modified, HLA-A2-matched, allogeneic, breast cancer cell line: Clinical and immunological results

Identification of tumor-specific antibodies in patients with breast cancer vaccinated with gene-modified allogeneic tumor cells

Immune effects of escalating doses of granulocyte-macrophage colony-stimulating factor added to a fixed, low-dose, inpatient interleukin-2 regimen: a randomized phase I trial in patients with metastatic melanoma and renal cell carcinoma

The Effects of Treatment with Interleukin-1α on Platelet Recovery after High-Dose Carboplatin

Computed tomography in staging of patients with melanoma metastatic to the regional nodes

Chronic Expanding Hematoma within a Periprosthetic Breast Capsule

A Randomized Placebo-Controlled Trial of Recombinant Human Interleukin-11 in Cancer Patients With Severe Thrombocytopenia Due To Chemotherapy

Interleukin 2 and lymphokine-activated killer cell therapy : analysis of a bolus interleukin 2 and a continuous infusion interleukin 2 regimen

Management of Parotid Leakage Following Rhytidectomy

Interleukin 1α Increases Serum Leptin Concentrations in Humans

The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies

Peripheral T lymphocytes from women with breast cancer exhibit abnormal protein expression of several signaling molecules

Phase II study of carmustine, dacarbazine, cisplatin, and tamoxifen in advanced melanoma: a Southwest Oncology Group study

Evaluation of a combined calcium sodium alginate and bio-occlusive membrane dressing in the management of split-thickness skin graft donor sites

Intraperitoneal lymphokine-activated killer-cell and interleukin-2 therapy for malignancies limited to the peritoneal cavity

Clinical evaluation of intraperitoneal Pseudomonas exotoxin immunoconjugate OVB3-PE in patients with ovarian cancer

Aktive Filter

Suchergebnisse filtern